Evoke (LON:EVOK) Trading Down 14.7% – Here’s Why

Evoke plc (LON:EVOKGet Free Report) shares were down 14.7% on Wednesday . The stock traded as low as GBX 57.50 ($0.74) and last traded at GBX 60.90 ($0.79). Approximately 4,320,929 shares traded hands during mid-day trading, an increase of 117% from the average daily volume of 1,992,749 shares. The stock had previously closed at GBX 71.40 ($0.92).

Wall Street Analysts Forecast Growth

EVOK has been the topic of a number of recent analyst reports. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank reduced their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.17) and set a “buy” rating on the stock in a report on Wednesday, December 4th.

Read Our Latest Analysis on Evoke

Evoke Trading Down 17.1 %

The business has a 50 day moving average of GBX 69.57 and a 200-day moving average of GBX 63.63. The firm has a market capitalization of £264.02 million, a P/E ratio of -1.48 and a beta of 0.84.

Evoke (LON:EVOKGet Free Report) last issued its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, analysts anticipate that Evoke plc will post 12.7648305 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Andrea Gisle Joosen purchased 14,572 shares of Evoke stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,206.11). Corporate insiders own 27.00% of the company’s stock.

About Evoke

(Get Free Report)

Read More

Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.